Linking pages
- Top FDA official overrules staff to approve gene therapy that failed trial | Ars Technica https://arstechnica.com/science/2024/06/top-fda-official-overrules-staff-to-approve-gene-therapy-that-failed-trial/ 256 comments
- The Field of Longevity Biotech is a Mess | PSBLAB https://psblab.org/?p=697 160 comments
- Dubious $56,000 Alzheimer’s drug spurs largest Medicare price hike ever | Ars Technica https://arstechnica.com/science/2021/11/dubious-56000-alzheimers-drug-spurs-largest-medicare-price-hike-ever/ 100 comments
- Spurred by Clarence Thomas, Ohio AG wants Google declared a public utility | Ars Technica https://arstechnica.com/tech-policy/2021/06/spurred-by-clarence-thomas-ohio-ag-wants-google-declared-a-public-utility/ 50 comments
- Controversial Alzheimer’s drug could cost US $334B—nearly half of DoD budget | Ars Technica https://arstechnica.com/science/2021/06/controversial-alzheimers-drug-could-cost-us-334b-nearly-half-of-dod-budget/ 17 comments
- FDA official behind Alzheimer’s drug scandal steps down | Ars Technica https://arstechnica.com/science/2023/02/fda-official-behind-alzheimers-drug-scandal-steps-down/ 11 comments
- FDA officials asked to step down after contentious Alzheimer’s drug approval | Ars Technica https://arstechnica.com/science/2021/06/advocacy-org-calls-for-ouster-of-fda-officials-after-alzheimers-drug-approval/ 4 comments
- Slamming and blasting https://voussoir.net/writing/slamming_and_blasting 2 comments
- Hackers can mess with HTTPS connections by sending data to your email server | Ars Technica https://arstechnica.com/gadgets/2021/06/hackers-can-mess-with-https-connections-by-sending-data-to-your-email-server/ 1 comment
- Maker of dubious $56K Alzheimer’s drug offers cognitive test no one can pass | Ars Technica https://arstechnica.com/science/2021/07/ever-forget-stuff-you-may-have-alzheimers-says-maker-of-56k-alzheimers-drug/ 0 comments
- FDA approves new Alzheimer’s treatment despite risks, unclear benefits | Ars Technica https://arstechnica.com/science/2023/01/fda-approves-new-alzheimers-treatment-despite-risks-unclear-benefits/ 0 comments
Linked pages
- https://blogs.sciencemag.org/pipeline/archives/2021/06/08/the-aducanumab-approval 120 comments
- Spurred by Clarence Thomas, Ohio AG wants Google declared a public utility | Ars Technica https://arstechnica.com/tech-policy/2021/06/spurred-by-clarence-thomas-ohio-ag-wants-google-declared-a-public-utility/ 50 comments
- Hackers can mess with HTTPS connections by sending data to your email server | Ars Technica https://arstechnica.com/gadgets/2021/06/hackers-can-mess-with-https-connections-by-sending-data-to-your-email-server/ 1 comment
Related searches:
Search whole site: site:arstechnica.com
Search title: A “disgraceful decision:” Researchers blast FDA for approving Alzheimer’s drug | Ars Technica
See how to search.